back to Scientific Program
Session 62
Friday – November 8, 2019
04:50 pm – 05:40 pm
Room 208 A+B (2nd floor)
Role of ablative therapies for esophageal disease
Chairs: Eun J. Shin (USA) – Zhizheng Ge (China)
- Which patients with Barrett’s esophagus or esophageal squamous cell dysplasia should be evaluated for ablative therapies? Ellen Stein (USA)
- How effective is radiofrequency ablation in treating Barrett’s esophagus associated neoplasia? Kulwinder S. Dua (USA)
- How effective is cryotherapy in treating Barrett’s esophagus associated neoplasia? Eun Ji Shin (USA)
- How effective is radiofrequency ablation in treating esophageal squamous cell dysplasia or early squamous cell esophageal cancer? Pichamol Jirapinyo (USA)
- How effective is cryotherapy in treating esophageal squamous cell dysplasia or early squamous cell esophageal cancer? Tossapol Kerdsirichairat (USA)
- How should patients with Barrett’s esophagus or esophageal squamous cell dysplasia be followed after ablative therapies? Andrew Taylor (Australia)
Contacts
Scientific coordination
R. Giuli, MD, FACS
Professor of Surgery
OESO – 2 Blvd Pershing
75017 Paris / France
Phone +33 (0)1 55 37 90 15
Organizing secretariat
Ms. Violet Liu
Beijing FC Vision
Commercial Service Ltd.
Dongzhimenwai Street, Dongcheng district, Beijing
Phone +86 1512 0032 285
Follow us
OESO is now active
on social media!
to get the latest on OESO news, announcements, events, and courses, and to let us know your thoughts!
©2018 OESO webdesign www.architecturevisualdesign.ch